Lv3
210 积分 2024-06-01 加入
Sacituzumab Govitecan in Untreated, Advanced Triple-Negative Breast Cancer
2个月前
已完结
Interferon-induced senescent CD8 + T cells reduce anti-PD1 immunotherapy efficacy in early triple-negative breast cancer
2个月前
已完结
Cancer biomarkers discovered using pan-cancer plasma proteomic profiling
3个月前
已完结
HEBP2-governed glutamine competition between tumor and macrophages dictates immunotherapy efficacy in triple-negative breast cancer
5个月前
已完结
KRT14 is a promising prognostic biomarker of breast cancer related to immune infiltration
5个月前
已完结
皖公网安备34019202002308
